As of 2025-09-17, the Relative Valuation of Royalty Pharma PLC (RPRX) is 35.44 USD. This relative valuation is based on P/E multiples. With the latest stock price at 35.64 USD, the upside of Royalty Pharma PLC based on Relative Valuation is -0.6%.
The range of the Relative Valuation is 32.84 - 38.43 USD.
| Range | Selected | |
| Trailing P/E multiples | 18.8x - 20.5x | 19.6x |
| Forward P/E multiples | 20.2x - 22.2x | 21.2x |
| Fair Price | 32.84 - 38.43 | 35.44 |
| Upside | -7.9% - 7.8% | -0.6% |
| Date | P/E |
| 2025-09-16 | 20.24 |
| 2025-09-15 | 20.08 |
| 2025-09-12 | 20.77 |
| 2025-09-11 | 20.97 |
| 2025-09-10 | 20.67 |
| 2025-09-09 | 20.85 |
| 2025-09-08 | 20.45 |
| 2025-09-05 | 20.61 |
| 2025-09-04 | 21.08 |
| 2025-09-03 | 20.94 |
| 2025-09-02 | 20.66 |
| 2025-08-29 | 20.56 |
| 2025-08-28 | 20.35 |
| 2025-08-27 | 20.60 |
| 2025-08-26 | 20.56 |
| 2025-08-25 | 20.56 |
| 2025-08-22 | 20.75 |
| 2025-08-21 | 20.74 |
| 2025-08-20 | 21.07 |
| 2025-08-19 | 20.57 |
| 2025-08-18 | 20.52 |
| 2025-08-15 | 20.77 |
| 2025-08-14 | 20.85 |
| 2025-08-13 | 20.83 |
| 2025-08-12 | 20.49 |
| 2025-08-11 | 20.68 |
| 2025-08-08 | 21.47 |
| 2025-08-07 | 21.14 |
| 2025-08-06 | 21.21 |
| 2025-08-05 | 21.66 |
| 2025-08-04 | 21.64 |
| 2025-08-01 | 21.20 |
| 2025-07-31 | 21.02 |
| 2025-07-30 | 21.21 |
| 2025-07-29 | 21.29 |
| 2025-07-28 | 21.17 |
| 2025-07-25 | 20.95 |
| 2025-07-24 | 20.90 |
| 2025-07-23 | 20.57 |
| 2025-07-22 | 20.62 |
| 2025-07-21 | 20.37 |
| 2025-07-18 | 20.33 |
| 2025-07-17 | 20.27 |
| 2025-07-16 | 20.34 |
| 2025-07-15 | 20.86 |
| 2025-07-14 | 20.70 |
| 2025-07-11 | 20.48 |
| 2025-07-10 | 20.64 |
| 2025-07-09 | 20.49 |
| 2025-07-08 | 20.29 |